News

Article

10-year data shows progressive visual decline in myopic children and adults

Author(s):

Key Takeaways

  • Over ten years, high myopia led to decreased BCVA and visual function, with increased moderate and severe visual impairment rates.
  • The study involved 568 eyes from 284 patients, with a mean baseline age of 22.49 years and spherical equivalent refraction of -9.72 diopters.
SHOW MORE

Chen and colleagues conducted a longitudinal study that included patients with high myopia who were followed for 10 years. Detailed ophthalmic examinations were conducted at the baseline and follow-up visits that included measurements of the BCVA and visual fields in 568 eyes of 284 patients.

(Image Credit: AdobeStock/oz)

(Image Credit: AdobeStock/oz)

A new study of Chinese children and adults that investigated the effects of progression of myopia found that over the course of 10 years the best-corrected visual acuity (BCVA) and the visual function decreased, with an increasing incidence rate of moderate and severe visual impairment.1 First author Yanping Chen, MD, from the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China, reported the results.

Chen and colleagues conducted a longitudinal study that included patients with high myopia who were followed for 10 years. Detailed ophthalmic examinations were conducted at the baseline and follow-up visits that included measurements of the BCVA and visual fields in 568 eyes of 284 patients.

The mean baseline age was 22.49 ± 13.07 years, spherical equivalent refraction (SER) −9.72 ± 3.02 diopters, and axial length 27.39 ± 1.53 mm.

Chen and colleagues found the following changes over a 10 year period: the mean BCVA loss was −0.06 logarithm of the minimum angle of resolution (95% confidence interval [CI], 0.05−0.07); the mean change rates in the mean deviation and pattern standard deviation were −0.07 decibel (dB)/year (95% CI, −0.08 to −0.06) and 0.036 dB/year (95% CI, 0.028 to 0.044), respectively; and the 10-year incidence rates of monocular moderate and severe visual impairment were 3.52% (95% CI, 2.16%–5.39%) and 6.35% (95% CI, 4.46%–8.72%), respectively.

The authors concluded, “In a highly myopic population, both the BCVA and visual fields deteriorated over time, with an increasing incidence of moderate and severe visual impairment. Raising public awareness of visual risks linked to high myopia and implementing strategies to reduce the burden in high-risk individuals are essential.”

Reference:
  1. Chen Y, Xiong R, Zhang J, et al. Ten-year change in visual function and incidence of visual impairment in highly myopic children and adults. Invest Ophthalmol Vis Sci. 2025; 66; doi: https://doi.org/10.1167/iovs.66.1.2

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.